, assessed by plethysmography, decreased by
0.7 mL/100 mL compared with placebo (P Â¼ .014).
Comparison with hydroxyrutoside and MPFF showed
similar effects on the symptoms. A more recent systematic review and meta-analysis16 included 10 highquality, double-blind, placebo-controlled RCTs with a
total number of 719 patients (CEAP C2-C5). Compared
with placebo,